ICM
ISZO Capital Management Portfolio holdings
AUM
$2M
This Quarter Return
+24.95%
1 Year Return
+35.61%
3 Year Return
+68.17%
5 Year Return
+471.86%
10 Year Return
–
AUM
$18.8M
AUM Growth
+$18.8M
(+152%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
61.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
7
Increased
1
Reduced
–
Closed
4
Top Buys
| 1 |
Lantheus
LNTH
|
$6.85M |
| 2 |
Novartis
NVS
|
$2.02M |
| 3 |
United Therapeutics
UTHR
|
$2.02M |
| 4 |
Invesco QQQ Trust
QQQ
|
$1.54M |
| 5 |
Novo Nordisk
NVO
|
$1.11M |
Top Sells
| 1 |
Lifecore Biomedical
LFCR
|
$2.42M |
| 2 |
CBL
CBL Properties
CBL
|
$1.81M |
| 3 |
Cryo-Cell International
CCEL
|
$825K |
| 4 |
Carvana
CVNA
|
$711K |
Sector Composition
| 1 | Healthcare | 71.28% |
| 2 | Energy | 0.03% |
| 3 | Consumer Discretionary | 0% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lantheus
LNTH
$3.73B
| $8.26M | 43.89% | 100,000 +82,923 | +486% | +$6.85M |
|
|
2
Novartis
NVS
$245B
| $2.02M | 10.76% | +22,000 | New | +$2.02M |
|
|
3
United Therapeutics
UTHR
$13.8B
| $2.02M | 10.71% | +9,000 | New | +$2.02M |
|
|
4
Invesco QQQ Trust
QQQ
$364B
| $1.54M | 8.19% | +4,800 | New | +$1.54M |
|
|
5
Novo Nordisk
NVO
$251B
| $1.11M | 5.92% | +7,000 | New | +$1.11M |
|
6
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.02M | 5.44% | +2,500 | New | +$1.02M |
|
|
FRC
7
DELISTED
First Republic Bank
FRC
| $727K | 3.87% | +52,000 | New | +$727K |
|
8
Amplify Energy
AMPY
$165M
| $6.55K | 0.03% | 953 | – | – |
|
|
CBL
9
CBL Properties
CBL
$985M
| – | – | -78,316 | Closed | -$1.81M |
|
|
10
Cryo-Cell International
CCEL
$37.9M
| – | – | -195,031 | Closed | -$825K |
|
|
11
Carvana
CVNA
$51.4B
| – | – | -150,000 | Closed | -$711K |
|
|
12
Lifecore Biomedical
LFCR
$285M
| – | – | -373,778 | Closed | -$2.42M |
|
|
CO
13
DELISTED
Global Cord Blood Corporation
CO
| $0 | ﹤0.01% | 279,495 | – | – |
|